Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2023-000036-30-PL
EUCTR2023-000036-30-PL
Active, not recruiting
Phase 1

A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma.

Medical University of Gdansk0 sites60 target enrollmentFebruary 20, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHepatoblastoma and liver cancer (hepatocarcinoma)Therapeutic area: Diseases [C] - Cancer [C04]
DrugsCisplatinum AccordCarboplatin AccordDoxorubicin-EbeweFluorouracil medacVINCRISTIN - RICHTERIrinotecan CSCEtopozyd AccordNexavarGemcitabine StridesOxaliplatinum Accord

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hepatoblastoma and liver cancer (hepatocarcinoma)
Sponsor
Medical University of Gdansk
Enrollment
60
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 20, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Clinically signs of Hepatoblastoma or Hepatocarcinoma (malignant tumors of the liver) \+ liver tumor; Age under 30; Signing informed consent to participate in the Study
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Previously or currently receiving chemotherapy treatment; Recurrence of the disease; Condition after organ transplantation; Uncontrolled generalized infection; Inability to conduct the Study in accordance with the Protocol; Other Associated Cancer; Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic Leukemia
EUCTR2017-002383-40-ITAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
Active, not recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic Leukemia
EUCTR2017-002383-40-CZAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
Active, not recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic Leukemiaacute promyelocytic leukemia (APL) in children and adolescentsTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2017-002383-40-SEAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
Not yet recruiting
Phase 2
Treatment study for children and adolescents with Acute Promyelocytic Leukemia
NL-OMON54336AIEOP- Associazione Italiana Ematologia Oncologia Pediatrica5
Active, not recruiting
Phase 1
Treatment study for children and adolescents with Acute Promyelocytic Leukemiaacute promyelocytic leukemia (APL) in children and adolescentsTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2017-002383-40-FRAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90